It was reported that this patient presented to the emergency room (er).The presenting electrogram (egm) indicated that the patient was exhibiting a ventricular tachycardia (vt) rhythm.There were also stored vt episodes exhibiting a rhythm in the 115 beat per minute (bpm) to 140 bpm range, which is in the programmed antitachycardia pacing (atp) therapy-only zone of the patients implanted cardiac resynchronization therapy defibrillator (crt-d) device.Fifty-five (55) rounds of atp therapy were provided across those stored episodes.The vt rhythm was not converted by the device therapy and atp therapy was exhausted.Boston scientific technical services (ts) reviewed these reports with the er physician and indicated that further review is recommended.Ts also called and spoke to the boston scientific representative (rep) that supports the associated healthcare facility (hcf) to let them know that they spoke with the er physician.The device remains in service.No patient symptoms or adverse patient effects were reported.
|